Skip to main content
SpringerLink
Log in

Just the facts: febrile neutropenia in the emergency department setting

  • Just the Facts
  • Published:
Canadian Journal of Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56-93.

    Article  Google Scholar 

  2. Zimmer AJ, Freifeld AG. Optimal management of neutropenic fever in patients with cancer. J Oncol Pract. 2019;15(1):19–24.

    Article  Google Scholar 

  3. Taplitz RA, Kennedy EB, Bow EJ, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol. 2018;36(14):1443–53.

    Article  Google Scholar 

  4. de Naurois J, Novitzky-Basso I, Gill MJ, et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21(Suppl 5):v252–6.

    Article  Google Scholar 

  5. Duceau B, Picard M, Pirracchio R, et al. Neutropenic enterocolitis in critically ill patients: spectrum of the disease and risk of invasive fungal disease. Crit Care Med. 2019;47(5):668–76.

    Article  Google Scholar 

  6. Hoeboer SH, van der Geest PJ, Nieboer D, et al. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2015;21(5):474–81.

    Article  CAS  Google Scholar 

  7. Verlinden A, De Vroey V, Goossens H, et al. Comparison of the power of procalcitonin and C-reactive protein to discriminate between different aetiologies of fever in prolonged profound neutropenia: a single-centre prospective observational study. Mediterr J Hematol Infect Dis. 2019;11(1):e2019023.

    Article  Google Scholar 

  8. Greco R, Barbanti MC, Mancini N, Crucitti L, Oltolini C, Forcina A, et al. Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients. Bone Marrow Transplant. 2018;53(4):410–6.

    Article  CAS  Google Scholar 

  9. Paul M, Dickstein Y, Schlesinger A, et al. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia. Cochrane Database Syst Rev. 2013;6:CD003038.

    Google Scholar 

  10. Klastersky J, Paesmans M. The multinational association for supportive care in cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer. 2013;21(5):1487–95.

    Article  Google Scholar 

  11. Coyne CJ, Le V, Brennan JJ, et al. Application of the MASCC and CISNE risk stratification scores to identify low-risk febrile neutropenic patients in the emergency department. Ann Emerg Med. 2017;69(6):755.

    Article  Google Scholar 

Download references

Acknowledgements

BL, ET, and EB conceived the idea for this manuscript, obtained permission for submission from Dr. Paul Atkinson, and contributed substantially to the writing and editing of the review. EB is a hematology/oncology physician and expert consultant. This manuscript did not utilize any grants or funding, and it has not been presented in abstract form. This clinical review has not been published, it is not under consideration for publication elsewhere, its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. This review does not reflect the views or opinions of the U.S. government, Department of Defense, U.S. Army, U.S. Air Force, or SAUSHEC EM Residency Program.

Author information

Author notes

  1. Brit Long

    Present address: Department of Emergency Medicine, Brooke Army Medical Center, 3841 Roger Brooke Dr, Fort Sam Houston, TX, 78234, USA

Authors and Affiliations

  1. Emergency Physician, North York General Hospital, Trillium Health Partners-Credit Valley Hospital Lecturer, University of Toronto, Toronto, Canada

    Elisha Targonsky

  2. Division of Hematology/Oncology, UC Irvine Health, Orange, CA, USA

    Elizabeth Brém

Authors
  1. Brit Long
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisha Targonsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elizabeth Brém
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brit Long.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Long, B., Targonsky, E. & Brém, E. Just the facts: febrile neutropenia in the emergency department setting. Can J Emerg Med 23, 445–449 (2021). https://doi.org/10.1007/s43678-020-00055-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43678-020-00055-x

Keywords

Search

Navigation